ResearchOpen Access02 Dec 2024 Communications Medicine Volume: 4, P: 256 Intratumoral heterogeneity drives acquired therapy resistance in a patient with metastatic prostate cancer Dena P. Rhinehart Jiaying Lai Laura A. Sena ResearchOpen Access02 Dec 2024 npj Precision Oncology Volume: 8, P: 275...
ResearchOpen Access20 Oct 2024 Scientific Reports Volume: 14, P: 24643 Racial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwards Examination of racial disparities in prostate cancer in the USA and UK highlights systemic, socio-economic and sociocul...
Prostate cancer - Latest News, Latest Research | CANCERactive 6 May 2021 LATEST NEWS AND RESEARCH ON PROSTATE CANCER Increase your personal odds of survival by empowering yourself with the latest research and news on prostate cancer; 'news you can use' today and incorporate into your ...
Cancer Prostate cancer treatment: Latest research Bryan Hughes PhD - June 10, 2019 0 Drugs and Medications Drugs to treat enlarged prostate found to delay prostate cancer diagnosis Man-tik Choy PhD - June 3, 2019 0 Prostate Cancer How does prostate cancer acquire drug resistance? Branson Chen...
CURE’s prostate cancer page is an extensive resource of cancer information featuring the latest prostate cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on prostate cancer....
In an interview with Targeted Oncology, Nasir Chaudry, MD, discussed the evolving landscape of prostate cancer treatment, driven by new research. Nasir Chaudry, MD With new data, the latest research, and ongoing clinical trials, the landscape of prostate cancer treatment continues to evolve. Acco...
The prostate cancer condition center is a comprehensive resource for cancer news & oncologist insights on prostate cancer. Read more about cancer at CURE.
Latest developments in prostate cancer researchtext editorEmerging Infectious Diseases
Deep transfer learning may elevate the capability of whole-body PET/CT scans to diagnose multiple cancers, ranging from breast cancer and lung cancer to melanoma and prostate cancer, according to new research presented at the SNMMI conference. ...
Latest News FDA fast tracks PT217 for neuroendocrine prostate cancer By Hannah Clarke December 5th 2024 PT217 is currently under investigation in the phase 1/2 SKYBRIDGE trial in patients with neuroendocrine cancers. The potential of HER2 targeting in prostate cancer: A case study with trastuzumab ...